{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:21:38Z","timestamp":1766067698980,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Ulcerative colitis (UC) treatment is mainly based on immunosuppressive therapy. As anti-inflammatory effects of sacral neuromodulation (SNM) have been previously reported in animal models, we conducted a pilot study aimed at assessing clinical, biological, and endoscopic response but also safety of SNM use in UC refractory to medical therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Adult patients with histologically proven UC resistant to immunosuppressive therapy were invited to enroll in the study. Primary outcome was the rate of UC remission (UCDAI score\u2009\u2264\u20092, without any criteria\u2009&gt;\u20091) at 8\u00a0weeks (W8). Secondary outcomes were biological and endoscopic response also evaluated at W8 and W16. Subsequently, every patient was followed every 6\u00a0months. Adverse events were prospectively collected for safety assessment during the follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight patients, with mean age 47\u00a0years old, suffering from UC for 2\u201313\u00a0years were included. There were no complications in relation to SNM procedure. The acceptance of the device was excellent in all patients. Clinical and endoscopic remission was obtained at W8 in one patient (12.5%) and three other patients (37.5%) were responders at W16. At review (mean follow-up of 4\u00a0years), two patients (25%) were in remission and two (25%) were responders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SNM application is safe in patients suffering from refractory UC. Effects on disease activity were mainly observed after 16\u00a0weeks. Larger prospective studies are mandatory, but SNM could be a way to reinforce medical therapy and reduce the use of immunosuppressive drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10151-023-02793-3","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T08:15:30Z","timestamp":1681287330000},"page":"501-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sacral neuromodulation for refractory ulcerative colitis: safety and efficacy in a prospective observational series of eight patients"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-7608","authenticated-orcid":false,"given":"Farouk","family":"Drissi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Bourreille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Neunlist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Meurette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"2793_CR1","doi-asserted-by":"publisher","first-page":"11365","DOI":"10.3390\/ijms222111365","volume":"22","author":"J Popov","year":"2021","unstructured":"Popov J, Caputi V, Nandeesha N et al (2021) Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies. Int  J Mol Sci 22:11365. https:\/\/doi.org\/10.3390\/ijms222111365","journal-title":"Int J Mol Sci"},{"key":"2793_CR2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","volume":"7","author":"J Burisch","year":"2013","unstructured":"Burisch J, Jess T, Martinato M, Lakatos PL (2013) The burden of inflammatory bowel disease in Europe. J Crohns Colitis 7:322\u2013337. https:\/\/doi.org\/10.1016\/j.crohns.2013.01.010","journal-title":"J Crohns Colitis"},{"key":"2793_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/codi.12410","volume":"16","author":"V Vitton","year":"2014","unstructured":"Vitton V, Soudan D, Siproudhis L et al (2014) Treatments of faecal incontinence: recommendations from the French National Society of Coloproctology. Colorectal Dis 16:159\u2013166. https:\/\/doi.org\/10.1111\/codi.12410","journal-title":"Colorectal Dis"},{"key":"2793_CR4","doi-asserted-by":"publisher","first-page":"G624","DOI":"10.1152\/ajpgi.00330.2019","volume":"318","author":"L Tu","year":"2020","unstructured":"Tu L, Gharibani P, Zhang N et al (2020) Anti-inflammatory effects of sacral nerve stimulation: a novel spinal afferent and vagal efferent pathway. Am J Physiol Gastrointest Liver Physiol 318:G624\u2013G634. https:\/\/doi.org\/10.1152\/ajpgi.00330.2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2793_CR5","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1113\/JP271783","volume":"594","author":"J Br\u00e9geon","year":"2016","unstructured":"Br\u00e9geon J, Coron E, Da Silva ACC et al (2016) Sacral nerve stimulation enhances early intestinal mucosal repair following mucosal injury in a pig model: sacral nerve stimulation enhances intestinal mucosal repair. J Physiol 594:4309\u20134323. https:\/\/doi.org\/10.1113\/JP271783","journal-title":"J Physiol"},{"key":"2793_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/MCG.0000000000000331","volume":"49","author":"J Br\u00e9geon","year":"2015","unstructured":"Br\u00e9geon J, Neunlist M, Bossard C et al (2015) Improvement of refractory ulcerative proctitis with sacral nerve stimulation. J Clin Gastroenterol 49:853\u2013857. https:\/\/doi.org\/10.1097\/MCG.0000000000000331","journal-title":"J Clin Gastroenterol"},{"key":"2793_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.crohns.2011.06.009","volume":"5","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet L, Ferrante M, Magro F et al (2011) Results from the 2nd Scientific Workshop of the ECCO (I): impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 5:477\u2013483. https:\/\/doi.org\/10.1016\/j.crohns.2011.06.009","journal-title":"J Crohns Colitis"},{"key":"2793_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13825","author":"N Zhang","year":"2020","unstructured":"Zhang N, Zhang H, Jiang L et al (2020) A novel method of sacral nerve stimulation for colonic inflammation. Neurogastroenterol Motility. https:\/\/doi.org\/10.1111\/nmo.13825","journal-title":"Neurogastroenterol Motility"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-023-02793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-023-02793-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-023-02793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:50:59Z","timestamp":1683762659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-023-02793-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2793"],"URL":"https:\/\/doi.org\/10.1007\/s10151-023-02793-3","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"type":"print","value":"1123-6337"},{"type":"electronic","value":"1128-045X"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no disclosure in relation to this study. Medtronic provided medical devices for sacral neuromodulation. The study design, data management, and statistical analysis were provided by academic funding from Nantes Hospital University Department of research. GM reports grants and non-financial support from Medtronic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was validated by the local Ethics committee (n\u00b016\/08-1006). All procedures performed in the study were in accordance with the Helsinki declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}